Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Harald Kluschanzoff has worked on the following 34 EPO patent applications which have been published in the last five years:

EP11194984

Multiple unit pellet tablet formulation comprising an opioid

IPC classification:
A61K 9/50, A61K 31/137, A61P 25/04
Applicant:
Hexal AG
Agent:
Harald Kluschanzoff, Hexal AG
Status:
APPLICATION WITHDRAWN
EP12007710

Orodispersible film compositions

IPC classification:
A61K 9/70, A61K 31/485, A61K 47/44
Applicant:
Hexal AG
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12008196

Oral pharmaceutical composition comprising dabigatran etexilate

IPC classification:
A61K 9/16
Applicant:
Hexal AG
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14187025

Crystalline methyl ester of rosuvastatin

IPC classification:
A61K 31/505, C07D 239/42
Applicant:
LEK Pharmaceuticals dd
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
GRANT OF PATENT INTENDED
EP13191659

Stabilized amorphous lorcaserin hydrochloride

IPC classification:
A61K 31/55, A61P 3/04, C07D 223/16
Applicant:
LEK Pharmaceuticals dd
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
APPLICATION REFUSED
EP13195067

Synthesis of vortioxetine via (2-(piperazine-1-yl)phenyl)lithium intermediates

IPC classification:
C07D 295/096
Applicant:
LEK Pharmaceuticals dd
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
APPLICATION REFUSED
EP13196935

Apparatus for simulating the function of human stomach and/or human intestine

IPC classification:
F04B 43/12, G09B 23/30
Applicant:
Sandoz AG
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
APPLICATION REFUSED
EP14151147

Synthesis of vortioxetine via (2-(piperazine-1-yl)phenyl)aniline intermediates

IPC classification:
A61K 31/495, A61P 25/24, C07D 295/096
Applicant:
LEK Pharmaceuticals dd
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
APPLICATION REFUSED
EP14159828

Synthesis of 2-arylmethyl-5-aryl-thiophene

IPC classification:
C07D 333/12, C07D 333/54, C07D 409/10
Applicant:
LEK Pharmaceuticals dd
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
APPLICATION REFUSED
EP14163774

Synthesis of vortioxetine via (2,4-dimethylphenyl)(2-iodophenyl)sulfane intermediate

IPC classification:
A61K 31/495, A61P 25/24, C07D 295/096
Applicant:
LEK Pharmaceuticals dd
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
APPLICATION REFUSED
EP14165135

Novel crystalline form of 1-(beta-D-glucopyranosyl)-4- methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene

IPC classification:
C07D 409/10
Applicant:
LEK Pharmaceuticals dd
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
APPLICATION REFUSED
EP14168813

Stereoselective synthesis of intermediates in the preparation of ss-C-arylglucosides

IPC classification:
C07D 309/10, C07D 407/12, C07D 409/10, C07F 1/08
Applicant:
LEK Pharmaceuticals dd
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
APPLICATION REFUSED
EP14170338

Processes for the preparation of ss-aminosulfone compounds

IPC classification:
C07C 315/04
Applicant:
LEK Pharmaceuticals dd
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
APPLICATION REFUSED
EP14178989

Novel hydrates of dolutegravir sodium

IPC classification:
A61K 31/5365, A61P 31/18, C07D 498/14
Applicant:
LEK Pharmaceuticals dd
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
APPLICATION REFUSED
EP14182755

Pharmaceutical compositions comprising Canagliflozin

IPC classification:
A61K 9/00, A61K 9/20, A61K 31/7042, A61P 3/10
Applicant:
Sandoz AG
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
APPLICATION REFUSED
EP14721256

PHARMACEUTICAL COMPOSITION CONTAINING CRYSTALLINE MACITENTAN

IPC classification:
A61K 9/20, A61K 31/506
Applicant:
Sandoz AG
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
EXAMINATION IN PROGRESS
EP14724472

TABLET WITH INCREASED DRUG LOAD OF ODANACATIB

IPC classification:
A61K 9/16, A61K 9/20, A61K 31/277
Applicant:
Sandoz AG
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
EXAMINATION REQUESTED
EP14724113

TABLET WITH INCREASED DRUG LOAD OF ODANACATIB

IPC classification:
A61K 9/16, A61K 9/20, A61K 31/277
Applicant:
Sandoz AG
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
EXAMINATION REQUESTED
EP14736339

1-[2-(2,4-DIMETHYLPHENYLSULFANYL) PHENYL]PIPERAZINE ACETATE IN CRYSTALLINE FORM

IPC classification:
A61K 31/495, A61P 25/00, C07D 295/096
Applicant:
LEK Pharmaceuticals dd
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
GRANT OF PATENT INTENDED
EP14198980

NOVEL SOLVATES OF N-[2-[(1S)-1-(3-ETHOXY-4-METHOXYPHENYL)-2-(METHYLSULFONYL)ETHYL]-2,3-DIHYDRO-1,3-DIOXO-1H-ISOINDOL-4-YL]ACETAMIDE

IPC classification:
A61K 31/4035, A61P 35/00, C07D 209/48
Applicant:
LEK Pharmaceuticals dd
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
APPLICATION REFUSED
EP15151449

Processes for preparing dolutegravir and analogues thereof

IPC classification:
C07D 498/14
Applicant:
LEK Pharmaceuticals dd
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
APPLICATION REFUSED
EP16157997

MULTI-DOSE DRY POWDER INHALERS

IPC classification:
A61K 9/12, A61K 9/14, A61K 31/167, A61P 11/06, A61P 11/08
Applicant:
Sandoz AG
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15162960

MODIFIED PARTICLES OF PALBOCICLIB

IPC classification:
A61K 31/519, A61P 35/00, C07D 471/04
Applicant:
Sandoz AG
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
APPLICATION REFUSED
EP15172082

A NOVEL SYNTHETIC PATHWAY TOWARDS APREMILAST

IPC classification:
C07C 315/04, C07F 5/02
Applicant:
LEK Pharmaceuticals dd
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
APPLICATION PUBLISHED
EP15185823

A SYNTHETIC PATHWAY TOWARDS APREMILAST

IPC classification:
C07C 315/00, C12P 17/10
Applicant:
LEK Pharmaceuticals dd
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
APPLICATION PUBLISHED
EP15188651

CRYSTALLINE ENCENICLINE HYDROCHLORIDE

IPC classification:
A61K 31/439, C07D 453/04
Applicant:
Sandoz AG
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
APPLICATION PUBLISHED
EP15189380

AFATINIB-CONTAINING FORMULATION

IPC classification:
A61K 9/14, A61K 9/16, A61K 9/20, A61K 31/517
Applicant:
Sandoz AG
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
APPLICATION PUBLISHED
EP15194610

CRYSTALLINE FORMS OF ENTINOSTAT

IPC classification:
A61K 31/4406, C07D 213/30
Applicant:
Sandoz AG
Agent:
PRÜFER & PARTNER mbB
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
APPLICATION PUBLISHED
EP15722530

PHARMACEUTICAL COMPOSITIONS OF EDOXABAN

IPC classification:
A61K 9/20, A61K 31/444, A61P 7/02
Applicant:
Sandoz AG
Agent:
PRÜFER & PARTNER mbB
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
EXAMINATION REQUESTED
EP15201150

CRYSTALLINE OMARIGLIPTIN SALTS

IPC classification:
A61K 31/4162, A61P 3/10, C07D 487/04
Applicant:
Sandoz AG
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
APPLICATION PUBLISHED
EP15201645

LEVODOPA AND CARBIDOPA MODIFIED RELEASE COMPOSITION

IPC classification:
A61K 9/16, A61K 9/48, A61K 31/194, A61K 31/195, A61K 31/198, A61K 45/06
Applicant:
Sandoz AG
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
APPLICATION PUBLISHED
EP15202426

PHARMACEUTICAL COMPOSITION OF VORTIOXETINE HYDROBROMIDE COMPRISING AN INERT CORE FORMED OF AN ACIDIC REACTING COMPOUND

IPC classification:
A61K 9/16, A61K 9/50, A61K 31/4465
Applicant:
Hexal AG
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
APPLICATION PUBLISHED
EP16150589

A NOVEL SYNTHETIC PATHWAY TOWARDS SOLITHROMYCIN AND PURIFICATION THEREOF

IPC classification:
C07H 1/00, C07H 17/08
Applicant:
LEK Pharmaceuticals dd
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
The application has been published
EP16151562

PHARMACEUTICAL COMPOSITION OF SELEXIPAG

IPC classification:
A61K 9/16
Applicant:
Sandoz AG
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
The application has been published

Please Sign in to use this feature